Damon Runyon Funds Young Investigators Studying Molecular Basis of Cancer | GenomeWeb

NEW YORK (GenomeWeb News) – The Damon Runyon Cancer Research Foundation has awarded $3.6 million to nine young investigators who are pursuing a range of efforts to better understand, and eventually treat, cancer at the molecular level.

The foundation said yesterday that it has named six new Damon Runyon Clinical Investigators, each of whom will receive $450,000 for three years to launch their projects, and three continuation grants of $300,000 each to previous awardees.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.